BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 29017957)

  • 1. Lifetime Risks, Projected Numbers, and Adverse Outcomes in Asian Patients With Atrial Fibrillation: A Report From the Taiwan Nationwide AF Cohort Study.
    Chao TF; Liu CJ; Tuan TC; Chen TJ; Hsieh MH; Lip GYH; Chen SA
    Chest; 2018 Feb; 153(2):453-466. PubMed ID: 29017957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 10-year nationwide trends of the incidence, prevalence, and adverse outcomes of non-valvular atrial fibrillation nationwide health insurance data covering the entire Korean population.
    Kim D; Yang PS; Jang E; Yu HT; Kim TH; Uhm JS; Kim JY; Pak HN; Lee MH; Joung B; Lip GY
    Am Heart J; 2018 Aug; 202():20-26. PubMed ID: 29802976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risks of Death and Stroke in Patients Undergoing Hemodialysis With New-Onset Atrial Fibrillation: A Competing-Risk Analysis of a Nationwide Cohort.
    Shih CJ; Ou SM; Chao PW; Kuo SC; Lee YJ; Yang CY; Tarng DC; Lin CC; Huang PH; Li SY; Chen YT
    Circulation; 2016 Jan; 133(3):265-72. PubMed ID: 26680239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early Rhythm Control and the Risks of Ischemic Stroke, Heart Failure, Mortality, and Adverse Events When Performed Early (<3 Months): A Nationwide Cohort Study of Newly Diagnosed Patients with Atrial Fibrillation.
    Chao TF; Chan YH; Chiang CE; Tuan TC; Liao JN; Chen TJ; Lip GYH; Chen SA
    Thromb Haemost; 2022 Nov; 122(11):1899-1910. PubMed ID: 35322396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence, incidence, and lifetime risk of atrial fibrillation in China: new insights into the global burden of atrial fibrillation.
    Guo Y; Tian Y; Wang H; Si Q; Wang Y; Lip GYH
    Chest; 2015 Jan; 147(1):109-119. PubMed ID: 24921459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atrial fibrillation incidence, prevalence, predictors, and adverse outcomes in acute coronary syndromes: A pooled analysis of data from 8 million patients.
    Noubiap JJ; Agbaedeng TA; Nyaga UF; Lau DH; Worthley MI; Nicholls SJ; Sanders P
    J Cardiovasc Electrophysiol; 2022 Mar; 33(3):414-422. PubMed ID: 34981859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temporal trends of the prevalence and incidence of atrial fibrillation and stroke among Asian patients with hypertrophic cardiomyopathy: A nationwide population-based study.
    Choi YJ; Choi EK; Han KD; Jung JH; Park J; Lee E; Choe W; Lee SR; Cha MJ; Lim WH; Oh S
    Int J Cardiol; 2018 Dec; 273():130-135. PubMed ID: 30150122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lifetime risk for development of atrial fibrillation: the Framingham Heart Study.
    Lloyd-Jones DM; Wang TJ; Leip EP; Larson MG; Levy D; Vasan RS; D'Agostino RB; Massaro JM; Beiser A; Wolf PA; Benjamin EJ
    Circulation; 2004 Aug; 110(9):1042-6. PubMed ID: 15313941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Ischemic Stroke, Major Bleeding, and Other Adverse Events With Warfarin Use vs Non-vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation With a History of Intracranial Hemorrhage.
    Tsai CT; Liao JN; Chiang CE; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chung FP; Chao TF; Lip GYH; Chen SA
    JAMA Netw Open; 2020 Jun; 3(6):e206424. PubMed ID: 32478848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of a Family History of Atrial Fibrillation With Incidence and Outcomes of Atrial Fibrillation: A Population-Based Family Cohort Study.
    Chang SH; Kuo CF; Chou IJ; See LC; Yu KH; Luo SF; Huang LH; Zhang W; Doherty M; Wen MS; Kuo CT; Yeh YH
    JAMA Cardiol; 2017 Aug; 2(8):863-870. PubMed ID: 28678986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Cumulative Incidence of Stroke, Myocardial infarction, Heart Failure and Sudden Cardiac Death in Patients with Atrial Fibrillation.
    Naser N; Kulic M; Dilic M; Dzubur A; Durak A; Pepic E; Smajic E; Kusljugic Z
    Med Arch; 2017 Oct; 71(5):316-319. PubMed ID: 29284897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atrial fibrillation prevalence, incidence and risk of stroke and all-cause death among Chinese.
    Chien KL; Su TC; Hsu HC; Chang WT; Chen PC; Chen MF; Lee YT
    Int J Cardiol; 2010 Mar; 139(2):173-80. PubMed ID: 19046608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modifiable lifestyle factors and lifetime risk of atrial fibrillation: longitudinal data from the Korea NHIS-HealS and UK Biobank cohorts.
    Park H; Kim D; Jang E; Yu HT; Kim TH; Kim DM; Sung JH; Pak HN; Lee MH; Lip GYH; Yang PS; Joung B
    BMC Med; 2024 May; 22(1):194. PubMed ID: 38735916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased risk of first-ever stroke in younger patients with atrial fibrillation not recommended for antithrombotic therapy by current guidelines: a population-based study in an East Asian cohort of 22 million people.
    Chang KC; Wang YC; Ko PY; Wu HP; Chen YW; Muo CH; Sung FC; Li TC; Hsu CY
    Mayo Clin Proc; 2014 Nov; 89(11):1487-97. PubMed ID: 25444485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral Anticoagulation in Very Elderly Patients With Atrial Fibrillation: A Nationwide Cohort Study.
    Chao TF; Liu CJ; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Liao JN; Chung FP; Chen TJ; Lip GYH; Chen SA
    Circulation; 2018 Jul; 138(1):37-47. PubMed ID: 29490992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-Vitamin K Antagonist Oral Anticoagulants in Elderly (≥85 years) Patients With Newly Diagnosed Atrial Fibrillation: Changing Clinical Practice and Outcomes for Stroke Prevention in a Nationwide Cohort Study.
    Cheng WH; Chiang CE; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Liao JN; Chung FP; Chen TJ; Lip GYH; Chen SA; Chao TF
    Mayo Clin Proc; 2021 Jan; 96(1):52-65. PubMed ID: 33413835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stroke risk in hypertrophic cardiomyopathy patients with atrial fibrillation: a nationwide database study.
    Hsu JC; Huang YT; Lin LY
    Aging (Albany NY); 2020 Nov; 12(23):24219-24227. PubMed ID: 33226371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in the incidence and prevalence of atrial fibrillation and estimated thromboembolic risk using the CHA
    Lee SR; Choi EK; Han KD; Cha MJ; Oh S
    Int J Cardiol; 2017 Jun; 236():226-231. PubMed ID: 28233629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of HATCH score in the prediction of new-onset atrial fibrillation for Asians.
    Suenari K; Chao TF; Liu CJ; Kihara Y; Chen TJ; Chen SA
    Medicine (Baltimore); 2017 Jan; 96(1):e5597. PubMed ID: 28072697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing the Effectiveness and Safety of Nonvitamin K Antagonist Oral Anticoagulants and Warfarin in Elderly Asian Patients With Atrial Fibrillation: A Nationwide Cohort Study.
    Chao TF; Chiang CE; Liao JN; Chen TJ; Lip GYH; Chen SA
    Chest; 2020 May; 157(5):1266-1277. PubMed ID: 31809694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.